NCT06700967View on ClinicalTrials.gov

Evaluating Pharmacogenomics-Based Pharmacotherapy in Real-World Settings for Schizophrenia

Not yet recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Schizophenia Disorder
Trial Locations (1)

Unknown

Shanghai Mental Health Center, Shanghai

All Listed Sponsors
lead

Shanghai Mental Health Center

OTHER

NCT06700967 - Evaluating Pharmacogenomics-Based Pharmacotherapy in Real-World Settings for Schizophrenia | Biotech Hunter | Biotech Hunter